NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
15.69
-0.36 (-2.24%)
At close: Aug 6, 2026, 4:00 PM EDT
15.70
+0.01 (0.05%)
After-hours: Aug 6, 2026, 5:17 PM EDT

NovoCure Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-148.57-136.23-168.63-207.04-92.53-58.35
Depreciation & Amortization
16.3114.6511.2410.9710.6210.25
Stock-Based Compensation
129.16104.83160.04115.61106.9694.9
Other Adjustments
-10.13-12.21-25.36-22.53-6.056.89
Change in Receivables
-18.63-38.94-26.3629.412.555.27
Changes in Inventories
-3.01-5.672.57-8.92-4.342.48
Changes in Accrued Expenses
30.9518.9619.1114.8714.2627.78
Changes in Other Operating Activities
1.115.571.04-5.71-0.67-6.46
Operating Cash Flow
-2.82-49.03-26.37-73.3430.7982.76
Operating Cash Flow Growth
-----62.80%-16.53%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-22.62-26.65-42.86-27.09-21.36-24.17
Purchases of Investments
-518.25-821.08-875.39-1,004-1,298-1,079
Proceeds from Sale of Investments
9501,2857781,2151,179958
Investing Cash Flow
409.13437.28-140.24184.15-139.96-144.83

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
99.9899.9896.92---
Long-Term Debt Repaid
-560.95-560.95-12.91-0.01-0.03-0.03
Net Long-Term Debt Issued (Repaid)
-460.97-460.9784.01-0.01-0.03-0.03
Issuance of Common Stock
7.079.776.3115.815.5225.73
Net Common Stock Issued (Repurchased)
7.079.776.3115.815.5225.73
Other Financing Activities
--0.15----
Financing Cash Flow
-454.6-451.3490.3215.7915.4925.7

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.240.39-0.170.13-0.1-0.19
Net Cash Flow
-48.52-62.7-76.47126.73-93.78-36.56

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-25.43-75.68-69.22-100.439.4358.59
Free Cash Flow Growth
-----83.90%-30.40%
FCF Margin
-3.64%-11.55%-11.44%-19.72%1.75%10.95%
Free Cash Flow Per Share
-0.22-0.68-0.64-0.940.090.56
Levered Free Cash Flow
-586.79-590.33-93.53-222.94-94.05-48.5
Unlevered Free Cash Flow
-127.49-146.91-228.11-267.34-102.7-39.8
SEC Filings: 10-K · 10-Q